Search

everythinglearnresearchcommunity

for

Search:↓

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

EP 2 receptor is essential for heart repair by helping macrophages work properly.

Biliary fibrosis is crucial in liver diseases and understanding it can help prevent and treat these conditions.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The article concludes that the wool follicle is a valuable model for studying tissue interactions and has potential for genetic improvements in wool production.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

Wnt signaling helps regenerate hair follicles by affecting how skin cells sense and respond to mechanical forces.

EDA is vital for bone and cartilage formation and could help treat skeletal disorders.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Myhre syndrome symptoms worsen over time, with specific genetic variants affecting severity.

Brentuximab may cause hair to regain color.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Using a stimulating cream shampoo before applying Minoxidil helps it penetrate hair follicles better, enhancing its hair growth-promoting effect.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.